We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Cardiology

Cardiology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Association of Common Ancestry-Enriched Variants With Cardiomyopathy and Arrhythmias: Insights From Genetic Studies in Individuals of African Ancestry
CardiologyAfrican ancestryarrhythmia

Association of Common Ancestry-Enriched Variants With Cardiomyopathy and Arrhythmias: Insights From Genetic Studies in Individuals of African Ancestry

By MedXY|Jun 26, 2026

Genetic variants enriched in individuals of African ancestry confer increased risk of cardiomyopathy and arrhythmias, with cardiovascular risk factors amplifying this risk. Large biobank studies enable reclassification of key variants and h

Evaluating Point-of-Care Ultrasound Accuracy for Right Ventricular Dysfunction in Pulmonary Embolism: A Comparative Analysis with Consultative Echocardiography
Cardiologyechocardiographyemergency medicine

Evaluating Point-of-Care Ultrasound Accuracy for Right Ventricular Dysfunction in Pulmonary Embolism: A Comparative Analysis with Consultative Echocardiography

By MedXY|Jun 26, 2026

This study assesses the accuracy of emergency physician-interpreted point-of-care ultrasound compared to cardiologist-interpreted consultative echocardiography for detecting right ventricular dysfunction in emergency patients with pulmonary

Multilevel Stewardship to Optimize Antithrombotic Therapy in DOAC Users: Lessons from a Veterans Health Initiative
CardiologyanticoagulationAntiplatelet Therapy

Multilevel Stewardship to Optimize Antithrombotic Therapy in DOAC Users: Lessons from a Veterans Health Initiative

By MedXY|Jun 25, 2026

A multicomponent stewardship intervention significantly reduced inappropriate antiplatelet prescription among patients on DOACs, decreasing bleeding risk, particularly in stable coronary artery disease.

Decoding Pulmonary Arterial Hypertension in Congenital Heart Disease: Latent Class Analysis Uncovers Distinct Risk Phenotypes and Treatment Insights
Cardiologycongenital heart diseasephenotyping

Decoding Pulmonary Arterial Hypertension in Congenital Heart Disease: Latent Class Analysis Uncovers Distinct Risk Phenotypes and Treatment Insights

By MedXY|Jun 25, 2026

Latent class analysis of 889 adult PAH-CHD patients identified unique phenogroups with distinct survival outcomes and treatment responses, offering refined risk stratification and guiding personalized therapy.

High-Normal Parathyroid Hormone Levels and Mortality: Insights from the ELSA-Brasil Study on Age and Sex Differences
CardiologyAge disparitiesCardiovascular Mortality

High-Normal Parathyroid Hormone Levels and Mortality: Insights from the ELSA-Brasil Study on Age and Sex Differences

By MedXY|Jun 24, 2026

Elevated parathyroid hormone at the high-normal range independently predicts greater cardiovascular and all-cause mortality, with marked sex and age disparities in a large middle-aged Brazilian cohort.

Evaluating the Impact of the OPTN Status Escalation Policy for Adult Heart Transplant Candidates on Durable LVAD Support
CardiologyHeart TransplantationLVAD

Evaluating the Impact of the OPTN Status Escalation Policy for Adult Heart Transplant Candidates on Durable LVAD Support

By MedXY|Jun 24, 2026

The OPTN’s new status escalation policy for stable adult heart transplant candidates with durable LVADs may benefit only a small fraction of patients, as most experience complications or transplant within six years.

Seven-Year Valve Durability Outcomes Comparing Transcatheter and Surgical Aortic Valve Replacement: Insights from the PARTNER 3 Randomized Trial
Cardiologybioprosthetic valve failureSurgical Aortic Valve Replacement

Seven-Year Valve Durability Outcomes Comparing Transcatheter and Surgical Aortic Valve Replacement: Insights from the PARTNER 3 Randomized Trial

By MedXY|Jun 24, 2026

An evidence-based review of the 7-year durability of transcatheter versus surgical aortic bioprosthetic valves in low-risk severe aortic stenosis patients, highlighting comparable long-term structural performance and need for reintervention

Cancer and Heart Failure in Scotland: Epidemiology, Interactions, and Prognostic Implications
Cardiologycancerepidemiology

Cancer and Heart Failure in Scotland: Epidemiology, Interactions, and Prognostic Implications

By MedXY|Jun 24, 2026

This review synthesizes evidence on the prevalence, incidence, and prognosis of cancer and heart failure comorbidity in Scotland, integrating recent cohort data and cardio-oncology research to inform clinical practice and future research di

Reevaluating the Ross Procedure in Adults: Insights from a Large Contemporary Cohort
CardiologyAortic Valve Diseaselong-term outcomes

Reevaluating the Ross Procedure in Adults: Insights from a Large Contemporary Cohort

By MedXY|Jun 24, 2026

The Ross procedure in adults demonstrates excellent long-term survival, valve durability, and low reintervention rates, supporting its broader use in selected patients at experienced centers.

Impact of Fructose-Containing Beverages and Foods from Childhood to Adulthood on Hypertension Risk: Evidence from the GUTS Cohort
Cardiologyfructosefruit intake

Impact of Fructose-Containing Beverages and Foods from Childhood to Adulthood on Hypertension Risk: Evidence from the GUTS Cohort

By MedXY|Jun 24, 2026

This prospective cohort study investigates how fructose-containing beverages and foods, including sugar-sweetened beverages, fruit juices, and whole fruits, consumed from childhood through adulthood influence hypertension risk, highlighting

Unveiling the Phenotype of Unclassified Pulmonary Hypertension: A Hidden Spectrum of Early Heart Failure with Preserved Ejection Fraction
CardiologyHFpEFHuyết Áp Phổi

Unveiling the Phenotype of Unclassified Pulmonary Hypertension: A Hidden Spectrum of Early Heart Failure with Preserved Ejection Fraction

By MedXY|Jun 20, 2026

Unclassified pulmonary hypertension often reflects early-stage HFpEF linked to left heart and metabolic dysfunction, identifiable via dynamic right heart catheterization and metabolomics.

Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical Trial
Cardiologybiomarkerschết đột ngột

Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical Trial

By MedXY|Jun 20, 2026

This study reveals that sudden death in heart failure patients often follows gradual clinical decline, challenging the notion that such deaths are always abrupt.

Decoding SLC4A3 Mutations in Short QT Syndrome: Insights from hiPSC-Derived Cardiomyocytes into Ventricular Arrhythmia and Sudden Cardiac Death
CardiologyarrhythmiahiPSC-CM

Decoding SLC4A3 Mutations in Short QT Syndrome: Insights from hiPSC-Derived Cardiomyocytes into Ventricular Arrhythmia and Sudden Cardiac Death

By MedXY|Jun 20, 2026

This article reviews how SLC4A3 gene mutations cause short QT syndrome by inducing intracellular alkalinization and altered ion channel currents, increasing arrhythmia risk, based on stem cell-derived cardiomyocyte models.

Decade-Long Outcomes of SAPIEN 3 TAVR vs. Surgery in Intermediate-Risk Aortic Stenosis Patients
Cardiologyintermediate-risklong-term outcomes

Decade-Long Outcomes of SAPIEN 3 TAVR vs. Surgery in Intermediate-Risk Aortic Stenosis Patients

By MedXY|Jun 20, 2026

This analysis reveals comparable 10-year mortality, valve durability, and hemodynamics between SAPIEN 3 transcatheter and surgical aortic valve replacement in intermediate-risk patients, underscoring TAVR’s durable benefit.

High-Dose Vitamin C After Cardiac Arrest: Promise Meets a Negative Signal in VITaCCA
Cardiologycardiac arrestcritical care

High-Dose Vitamin C After Cardiac Arrest: Promise Meets a Negative Signal in VITaCCA

By MedXY|Jun 19, 2026

In a multicenter phase 2 trial, early intravenous vitamin C did not improve post-cardiac arrest organ dysfunction and the 10 g dose was associated with worse outcomes, including renal, cardiac, and neurologic signals.

Updated COVID-19 Vaccination and Cardiovascular Protection: What a Large VA Study Found in 2024-2025
CardiologyCOVID-19 vaccinemajor adverse cardiovascular events

Updated COVID-19 Vaccination and Cardiovascular Protection: What a Large VA Study Found in 2024-2025

By MedXY|Jun 19, 2026

In over 1 million US veterans, the 2024-2025 COVID-19 vaccine was associated with fewer COVID-19-related cardiovascular events, with the strongest benefit in adults over 75 and those with comorbidities.

Tirzepatide vs Dulaglutide: New Post Hoc SURPASS-CVOT Data Point to Broader Cardiorenal Benefit
Cardiologycardiorenal outcomesdulaglutide

Tirzepatide vs Dulaglutide: New Post Hoc SURPASS-CVOT Data Point to Broader Cardiorenal Benefit

By MedXY|Jun 19, 2026

Post hoc SURPASS-CVOT analysis found tirzepatide lowered a broad 6-component cardiorenal composite versus dulaglutide in high-risk patients with type 2 diabetes, with more gastrointestinal adverse events but similar overall safety.

Postoperative Atrial Fibrillation After Cardiac Surgery: Common, Variably Treated, and Linked to Worse 1-Year Outcomes
Cardiologyanticoagulationcardiac surgery

Postoperative Atrial Fibrillation After Cardiac Surgery: Common, Variably Treated, and Linked to Worse 1-Year Outcomes

By MedXY|Jun 19, 2026

The VISION Cardiac Surgery cohort found POAF in about one-third of patients, with wide variation in discharge treatment. POAF strongly predicted later atrial fibrillation and was associated with higher 1-year mortality.

10-Year Randomized Outcomes of Transcatheter or Surgical Aortic Valve Replacement in Intermediate-Risk Aortic Stenosis: What PARTNER 2A Adds to the Long-Term TAVR Evidence Base
Cardiologyaortic stenosislong-term outcomes

10-Year Randomized Outcomes of Transcatheter or Surgical Aortic Valve Replacement in Intermediate-Risk Aortic Stenosis: What PARTNER 2A Adds to the Long-Term TAVR Evidence Base

By MedXY|Jun 17, 2026

The PARTNER 2A 10-year data show higher mortality and reintervention with balloon-expandable SAPIEN XT TAVR versus surgery in intermediate-risk patients, driven mainly by transthoracic access. Contemporary 10-year SAPIEN 3 data, however, su

Cardiologycalcium channelCaV1.2

Galectin-3 Regulates Smooth Muscle Contraction and Blood Pressure by Modulating CaV1.2 Channel Function

By MedXY|Jun 17, 2026

Researchers found that Galectin-3 boosts CaV1.2 calcium channel activity in blood vessel muscle, increasing contraction and blood pressure. Blocking this interaction lowered blood pressure in animal models, suggesting a new target for hyper

Prev
15 / 25
1…1314151617…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles